Altos Labs Stock

altoslabs.comHealthcare / BioTech & PharmaFounded: 2021Funding to Date: $2.62B

Altos Labs is an American biotechnology research company founded in 2022 and focused on cellular rejuvenation programming to restore cell health and resilience, with the goal of reversing disease to transform medicine. Altos has operations in San Francisco, San Diego, and in Cambridge, UK, with significant collaborations in Japan, with a Board of Directors and advisors including Nobel Laureates and scientific leaders.

Register To Buy and Sell Shares

For more details on financing and valuation for Altos Labs, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in


Enterprise Value

Powered by Forge Data

Access Altos Labs’ valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Altos Labs.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.


Animation displayed is not current and securities are shown for illustrative purposes only.


Management Team

Hans Bishop
Co-Founder & President
Ann Lee-Karlon Ph.D
Chief Operating Officer
Hal Barron MD
Chief Executive Officer
Richard Klausner MD
Co-Founder & Chief Scientist

Frequently Asked Questions About Altos Labs’ Stock

Can you buy Altos Labs’ stock?
Altos Labs is not publicly traded on NYSE or NASDAQ in the U.S. To buy Altos Labs’ stock you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.
Can you sell Altos Labs’ stock?
Yes, you can sell stock of a private company like Altos Labs. Forge can help you sell your Altos Labs stock in a way that works for you and the company. So if you are seeking liquidity, register with us today to get started.
What is Altos Labs’ stock price?
Altos Labs is a privately held company and therefore does not have a public stock price. However, you may access Altos Labs’ private market stock price with Forge Data.
What is Altos Labs’ stock ticker symbol?
Altos Labs does not have an official ticker symbol because this company is not currently publicly traded.
Can institutional investors buy and sell private market stocks?
Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

News Highlights

For This Venture Capitalist, Research on Aging Is Personal; ‘Bob Has a Big Fear of Death’
The investment firm Robert Nelsen co-founded in 1986, Arch Venture Partners, has racked up billions in profits from early stakes in companies developing methods to detect and treat cancer and other diseases.
Altos Labs launches with the goal to transform medicine through cellular rejuvenation programming
Altos Labs™ (Altos™) launched today as a new biotechnology company dedicated to unraveling the deep biology of cellular rejuvenation programming. Altos' mission is to restore cell health and resilience to reverse disease, injury, and the disabilities that can occur throughout life. The company launches with a community of leading scientists, clinicians, and leaders from both academia and industry working together towards this common mission.
Updated on: Apr 13, 2024


Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.